key: cord-0427521-j3cfdjxv
authors: Honce, Rebekah; Vazquez-Pagan, Ana; Livingston, Brandi; Cherry, Sean; Hargest, Virginia; Sharp, Bridgett; Van de Velde, Lee-Ann; Skinner, R. Chris; Thomas, Paul G.; Schultz-Cherry, Stacey
title: Improved metabolic syndrome and timing of weight loss is crucial for influenza vaccine-induced immunity in obese mice
date: 2022-04-17
journal: bioRxiv
DOI: 10.1101/2022.04.16.488487
sha: 2f6b49bd713c5609d0dea13bc8a7f2b58821f778
doc_id: 427521
cord_uid: j3cfdjxv

Persons with obesity are at higher risk for developing severe complications upon influenza virus infection making vaccination a priority. Yet, studies demonstrate vaccine responses are less effective in obese hosts. In these studies, we examined how the timing of weight loss influenced influenza vaccine efficacy in male and female diet- induced obese mice. Here, we show weight loss post-vaccination is insufficient to rescue poor vaccine efficacy; however, weight loss occurring pre-vaccination successfully improves outcomes at viral challenge. Pre-vaccination weight loss improved vaccine immunogenicity and restored a functional recall response at challenge. Through tracking sera metabolic biomarkers, we propose the metabolic state at the time of vaccination is predictive of vaccine immunogenicity. Altogether, these findings highlight how timing of host-directed interventions is vital when seeking to improve influenza vaccine immunogenicity in obese hosts.

2 Abstract (131) 24 Persons with obesity are at higher risk for developing severe complications upon 25 influenza virus infection making vaccination a priority. Yet, studies demonstrate vaccine 26 responses are less effective in obese hosts. In these studies, we examined how the 27 timing of weight loss influenced influenza vaccine efficacy in male and female diet-28 induced obese mice. Here, we show weight loss post-vaccination is insufficient to 29 rescue poor vaccine efficacy; however, weight loss occurring pre-vaccination 30 successfully improves outcomes at viral challenge. Pre-vaccination weight loss 31 improved vaccine immunogenicity and restored a functional recall response at 32 challenge. Through tracking sera metabolic biomarkers, we propose the metabolic state 33 at the time of vaccination is predictive of vaccine immunogenicity. Altogether, these 34 findings highlight how timing of host-directed interventions is vital when seeking to 35 improve influenza vaccine immunogenicity in obese hosts. 36 3

37 Introduction (463) 38 Obesity is a leading cause of global morbidity as it underlies many non-communicable 39 diseases, such as cardiovascular disease and several cancers 1 . As obesity's 40 prevalence increases, we have begun to appreciate its impact on susceptibility to and 41 severity of communicable diseases 2,3 . Epidemiological and empirical studies suggest 42 obesity increases severity of bacterial 4-6 , viral 7 , fungal 8 , and parasitic 9,10 infections. After 43 the 2009 H1N1 influenza virus pandemic, obesity was identified as an independent risk 44 factor for hospitalization, need for intensive care, and death upon infection 11 . These 45 trends are mirrored in the COVID-19 pandemic 12 . 46 Prevention through vaccination is the best control strategy for many infectious 47 diseases. However, previous studies in our lab and others determined obesity may 48 weaken influenza immunization efficacy [13] [14] [15] 20, 21 . In these studies, we asked if host interventions, such as weight loss, could 56 improve immune responses to whole, inactivated influenza viruses in a mouse model of 57 diet-induced obesity. 58 4

To answer our overarching question, we maintained wild-type C57Bl/6J mice on 59 either high-fat, calorically dense diet (HFD) or standard chow for 16 weeks. After four 60 months of exposure to primary diets, mice were vaccinated with inactivated H1N1 61 influenza virus. Following immunization, a subset of HFD-exposed mice was swapped 62 to standard chow. This secondary diet continued for either 4 weeks (short-term) or 12 63 weeks (long-term), at which time homotypic viral challenge with a lethal dose of H1N1 64 virus occurred. Neither short-nor long-term weight loss post-vaccination improved viral 65 clearance, seroconversion, or survival upon challenge in formerly obese mice. However, 66 survival outcomes were improved-and indistinguishable from always lean mice-if 67 weight loss occurred prior to vaccination. By monitoring markers of adipose tissue 68 function, we found that high leptin, low adiponectin, and a low adiponectin:leptin ratio at Poor infection outcomes, regardless of vaccination status, is a hallmark of influenza 82 pathogenesis in obese mice 16, 22 . To determine if weight loss is sufficient to improve 83 survival outcomes after immunization, we randomized whole cages to either HFD or 84 standard chow for 16 weeks 23 after which mice were vaccinated with whole, inactivated 85 H1N1 influenza virus (Fig. 1a) . Each experimental group consisted of n=20 mice with 86 half serving as unvaccinated controls. At the time of vaccination, HFD and chow-fed 87 groups had significant differences in weight (p<0.0001, Fig. 1b, c) . Two weeks post-88 vaccination, diets were switched to create three cohorts: always obese (HFD>HFD), 89 always lean (Lean>Lean), and formerly obese (HFD>Lean) mice. During the post-diet 90 switch, formerly obese mice displayed notable weight loss compared to always obese 91 mice (p<0.0001, Fig. 1b, c) . 92 At 1-month post-diet switch, mice were challenged with 10X mouse lethal dose-93 50 (MLD 50 ) A/California/04/2009 (CA/09) as indicated (Fig. 1a) and monitored for 94 morbidity and mortality. In contrast to mock-or always lean groups, vaccinated always 95 obese mice were not protected from morbidity or mortality as 100% lethality was 96 observed ( Fig. 1d-f ). This was also true in formerly obese mice. Weight loss post-97 vaccination failed to attenuate infection-related weight loss (p=0.1003, Fig. 1d ) but did 98 statistically reduce signs of infection (p=0.0462, Fig. 1e ), although this is not biologically 99 relevant as survival of formerly obese mice was not improved compared to survival 100 rates in always lean mice (p=0.6771, Fig. 1f ). Overall, vaccination resulted in survival of 101 100% of always lean, 0% of always obese and 24% of formerly obese mice. 102 We considered that longer-term weight loss may be needed to protect formerly 103 obese mice. However, even at 12 weeks post-diet switch, vaccination did not improve 104 6 survival outcomes in formerly obese mice (Supplemental Fig. 1 ). Weight trends were 105 comparable to short-term diet switch mice (Supplemental Fig. 1a-c) . At challenge, 106 improvements in morbidity were noted but survival was not improved for mice 107 vaccinated while obese (Supplemental Fig. 1d-f ). Compared to mock vaccinated 108 controls, vaccinated always lean mice were 100% protected from viral challenge 109 (p=0.0001), but we observed poor survival outcomes (0% and 28%, respectively) in 110 always obese and formerly obese mice (Supplemental Fig. 1f ). In conjunction with the 111 short-term experiment, these studies attest diet group at time of vaccination is predictive 112 of survival at challenge in mice. 145 control of viral spread 146 To better understand why the vaccine failed to protect formerly obese mice, we 147 monitored viral titers and spread, lung histopathology, and interferon responses. 148 Survival trends were similar between short-and long-term diet protocols, thus, the 149 remaining studies were performed using the short-term protocol. At days 3 and 7 post-150 8 infection (p.i.), reduced viral titers were only observed in the always lean vaccinated diet 151 group (Fig. 2a ). There were no differences between the obese or formerly obese 152 groups. As obesity is associated with increased viral spread in the lungs 27,30 , we 153 performed in situ hybridization (ISH) for the nonstructural gene (NS1, Fig. 2b ). In always 154 obese mice, marked viral spread was noted at day 3 p.i. (white arrow, Fig. 2b we found that mice vaccinated while obese have significantly reduced overall CD4 + 243 (p=0.0021, Fig. 6a ) and CD8 + (p=0.0041, Fig. 6b ) T-cell numbers in the spleen while 244 also trending towards reduced B220 + B-cell numbers as compared to vaccinated, 245 always lean mice (Fig. 6c) . Always lean mice also exhibit increased numbers of CD4 + 246 T EFM and CD4 + T CM (p=0.0007) cells compared to always obese mice suggesting body 247 weight at vaccination can influence the generation of a CD4 + T-cell memory response 248 (Fig. 4) . This trend was consistent, albeit not statistically significant (p=0.0831) with an 249 increased frequency in CD4 + T CM cells in mice vaccinated while lean as compared to 250 mice vaccinated while obese ( Fig. 6d-g) . No significant differences were observed 251 between CD8 + T EFM and CD8 + T CM numbers (Fig. 6e, g) . These data highlight how Fig. 8) . Thus, we 262 hypothesized that improved metabolic health, even with a history of diet-induced 263 obesity, would be sufficient to preserve vaccine efficacy. To test, formerly obese mice 264 were transferred to control diet for a 4-week wash-out period (Fig. 7a) . At this time, 265 13 weight (p<0.0001, Fig. 7b, c) and metabolic measures, including leptin (p<0.0001, Fig.   266 7d), are near or approaching the lean baseline. After vaccination, we allowed 3 weeks 267 to elicit vaccine responses on secondary diets and mice were ultimately challenged as 268 before (Fig. 7a) . Contrary to weight loss after vaccination (Fig. 1-5) , vaccination 1-month 269 post-diet switch significantly improved morbidity in formerly obese mice (Fig. 7e, f;   270 p<0.0001, p<0.0001) compared to mock vaccinated mice (p=0.0715, p<0.0001), which 271 translated to mortality (Fig. 7g) . Consistent with previous studies, we observed no 272 survival in vaccinated always obese mice and complete survival in vaccinated always 273 lean mice (Fig. 7g, p=0.0249) , which accompanied decreased viral load at day 7 p.i. In 274 vaccinated always lean and formerly obese mice (Fig. 7h ) and increased HAI titers (Fig.   275 7i). The frequency and numbers of CD4 + and CD8 + lung T-cells also increased within 276 lung tissue at day 7 p.i. (Fig. 8a, Supplemental Fig. 9a ) in formerly obese mice 277 vaccinated after weight loss, which was paired with a reduction in circulating CD4 + and 278 CD8 + T-cell numbers (Fig. 8b, Supplemental Fig. 9b) (Fig. 1, Supplemental Fig. 1 ), yet weight loss pre-vaccination resulted in 296 100% of formerly obese mice surviving challenge (Fig. 7) . Essentially, the snapshot of 2) and improved effectiveness of a cellular recall to the lung at challenge (Fig. 3, 4) , all 334 culminating in high survival probability (Fig. 1, Supplemental Fig. 1 ). 335 Adipokines, especially leptin, are implicated in attenuating both innate and 336 adaptive immune responses in high-risk populations and are highly responsive to diet 337 status 53,54 . Our HFD was 60% fat, with lard as the primary source. Lard is high in Table 1 ). For studies concerning weight change prior to vaccination, 455 mice were randomized to control diet or HFD as before. After 4 months, half were 456 switched to the opposing diet for 1 month prior to vaccination and were ultimately 457 challenged 1 month after vaccination. include data up to timepoints for any censored mice (Supplemental Table 1 

Obesity: global epidemiology and pathogenesis

Body mass index and the risk of infection -from underweight 583 to obesity

The Impact of Obesity and Diabetes on the Risk of Disease

Death due to Invasive Group A Streptococcus Infections in Adults

Infection with the Lyme disease pathogen suppresses innate 588 immunity in mice with diet-induced obesity

Obesity Exacerbates the Cytokine Storm Elicited by 590

Francisella tularensis Infection of Females and Is Associated with Increased 591

Obesity as a risk factor for 593 severe influenza-like illness

Immune responsiveness in a rat model for type II diabetes 595 (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte 596 function

Obesity and Diabetes as Risk Factors for Severe Plasmodium 598 falciparum Malaria: Results From a Swedish Nationwide Study

Diet-induced obesity promotes systemic inflammation and 601 increased susceptibility to murine visceral leishmaniasis

Risk factors for severe outcomes following 2009 604 influenza A (H1N1) infection: a global pooled analysis

Obesity is a risk factor for developing critical condition in COVID-19 607 patients: A systematic review and meta-analysis

Diet-induced obesity dramatically reduces the efficacy of a 2009 610 pandemic H1N1 vaccine in a mouse model

Obesity-induced chronic inflammation is associated with the 612 reduced efficacy of influenza vaccine

Obesity is associated with impaired immune response to 614 influenza vaccination in humans

Obesity Outweighs Protection Conferred by Adjuvanted 616 Influenza Vaccination

Diet-induced obesity impairs the T 618 cell memory response to influenza virus infection

Increased risk of influenza among vaccinated adults who are 620 obese

Impact of Obesity and Metabolic 622 Syndrome on Immunity

Macrophages Mediate Increased CD8 T Cell Inflammation During 624

Weight Loss in Formerly Obese Mice

Metabolite profiling of obese individuals before and after a one year weight loss 627 program

Obesity Increases Mortality and Modulates the Lung Metabolome 629 during Pandemic H1N1 Influenza Virus Infection in Mice

The development of diet-induced obesity and glucose 632 intolerance in C57BL/6 mice on a high-fat diet consists of distinct phases

Sex differences in immune responses

Obesity and Sex Affect the Immune Responses to Tick-637

Severe Obesity, Increasing Age and Male Sex Are 639

Independently Associated With Worse In-Hospital Outcomes, and Higher In-Hospital 640

a Cohort of Patients With COVID-19 in the

Absence of beta6 Integrin Reduces Influenza Disease Severity in Highly Susceptible 644

The Role of Sex and Sex Hormones

Regulating Obesity-Induced Inflammation

The impact of age and sex on body composition and glucose 648 sensitivity in C57BL/6J mice

Obesity-Related Microenvironment Promotes Emergence of Virulent 650 Influenza Virus Strains

Genes as Enhancers of Antiviral Innate Immune Signaling

Obesity worsens the outcome of influenza virus infection 655 associated with impaired type I interferon induction in mice

Immunological assessment of influenza vaccines and immune 658 correlates of protection

With Impaired Memory T-Cell Response to Influenza and Are Not Reversed With 661 Weight Loss

Dynamically linking influenza virus infection kinetics, lung injury, 663 inflammation, and disease severity

Obesity or obesities? Controversies 665 on the association between body mass index and premature mortality

Time to redefine body mass index categories in chronic diseases? 668 Spotlight on obesity paradox

Metabolic Syndrome and Viral 670 Pathogenesis: Lessons from Influenza and Coronaviruses

Systematic 673 Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection

Risk Stratification in the West Virginian Population

Role of Leptin in Inflammation and Vice Versa

Adiponectin-leptin 679 ratio: A promising index to estimate adipose tissue dysfunction. Relation with 680 obesity-associated cardiometabolic risk

Insulin as an 682 immunomodulatory hormone

Dietary fat, insulin sensitivity and the 684 metabolic syndrome

Obesity and respiratory infections: does excess adiposity weigh down 686 host defense?

Leptin mediates the pathogenesis of severe 2009 pandemic 688 influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-689 induced obesity

The role of leptin and ghrelin in the 691 regulation of food intake and body weight in humans: a review

Influenza in High-Risk Hosts: Lessons Learned from Animal Models

Diet-induced obesity reduces the production of influenza vaccine-697 induced antibodies via impaired macrophage function

Overweight and obese adult humans have a defective cellular 700 immune response to pandemic H1N1 influenza A virus

Dysregulated Type I Interferon and Inflammatory 703

Responses Cause Lethal Pneumonia in SARS-CoV-Infected

Influenza virus-related critical illness: pathophysiology 706 and epidemiology

Cell Differentiation via PI3K p110δ-Akt-Mediated Signals

Reliability of leptin, but not adiponectin, as a 711 biomarker for diet-induced weight loss in humans

Dietary Components 713 in the Development of Leptin Resistance

Influence of dietary saturated fat content on adiposity

behavior, inflammation, and metabolism: composition matters

Inflammation, Toll-Like Receptor 4 and Fatty 718

A saturated fatty acid-rich diet induces an obesity-linked 720 proinflammatory gene expression profile in adipose tissue of subjects at risk of 721 metabolic syndrome

High-fat and high-sucrose (western) diet induces steatohepatitis 723 that is dependent on fructokinase

Fourth Revised Edition

Sulfur Compounds Inhibit High Glucose-Induced Inflammation by 727

Regulating NF-κB Signaling in Human Monocytes

Acute effects of feeding fructose, 729 glucose and sucrose on blood lipid levels and systemic inflammation

Fructose stimulated de novo lipogenesis is promoted by 732 inflammation

Acute intake of a high-fructose diet alters the balance of 734 adipokine concentrations and induces neutrophil influx in the liver

Effect of Dietary Sugar Intake on Biomarkers of Subclinical 737 Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies

Leptin induces 742 immunosenescence in human B cells

Metabolic 744 requirements of human pro-inflammatory B cells in aging and obesity

Negative legacy of obesity

Long-lasting effect of obesity on skeletal muscle transcriptome

Mammary Tumor Growth Persist in Formerly Obese Mice

A short-term transition from a high-fat diet to a normal-fat diet before 753 pregnancy exacerbates female mouse offspring obesity

Enriched environment-induced maternal weight loss reprograms 756 metabolic gene expression in mouse offspring

Caloric Restriction Promotes Immunometabolic Reprogramming 758 Leading to Protection from Tuberculosis

Divergent compensatory responses to high-fat diet between 760

inbred mouse strains

Metabolic remodeling of white adipose tissue in obesity

Transforming growth factor beta1 765 release by human adipose tissue is enhanced in obesity

High-Fat Diet Rapidly Modifies Trafficking, Phenotype, and Function 768 of Plasmacytoid Dendritic Cells in Adipose Tissue

Obesity Expands a Distinct Population of T Cells in Adipose Tissue 771 and Increases Vulnerability to Infection

Fat Diet on the Formation of Pulmonary Neutrophil Extracellular Traps during 774 Influenza Pneumonia in BALB/c Mice

A guide to immunometabolism for 776 immunologists

The effects of diet on inflammation: 778 emphasis on the metabolic syndrome

Modulation of immune and inflammatory responses by dietary lipids

The N501Y mutation in SARS-CoV-2 spike leads to 782 morbidity in obese and aged mice and is neutralized by convalescent and post-783 vaccination human sera

Hepatitis B vaccine response 786 in obesity: A meta-analysis

Respiratory 788 syncytial virus infection in elderly and high-risk adults

Association of Weight Loss Achieved Through Metabolic Surgery 791

With Risk and Severity of COVID-19 Infection

The effects of vaccine timing on the efficacy of an acute 794 eccentric exercise intervention on the immune response to an influenza vaccine in 795 young adults

Moderate exercise improves antibody response to influenza 797 immunization in older adults

Cardiovascular exercise training extends influenza vaccine 799 seroprotection in sedentary older adults: the immune function intervention trial

Leptin-based 802 adjuvants: an innovative approach to improve vaccine response

Impaired wound healing predisposes obese mice to severe 805 influenza virus infection

Pomace Consumption Favorably Alters Hepatic Lipid Metabolism in Young Female 808

Rats Fed a Western Diet

Detection of Antibody to Avian Influenza A (H5N1) Virus in Human 810 Serum by Using a Combination of Serologic Assays

One-way and Two-way ANOVA Models

Estimation of Effect Size 815 Indices and Standardized Parameters

 395 The authors gratefully acknowledge the expert technical assistance and scientific 396 discussions from Dr. Ericka Roubidoux, Kristin Wiggins, Brandi Clark, members of the 397 Schultz-Cherry and Thomas labs, and pathological expertise of Dr. Peter Vogel. We